Stefano Lepori

Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study

Francesco Raspagliesi, Giuseppa Maltese, Giorgio Bogani et al. · Gynecologic Oncology · 2016 · 88 citations

Medicine, Oncology, Surgery +11

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial

Domenica Lorusso, Giovanni Scambia, Sandro Pignata et al. · Annals of Oncology · 2015 · 55 citations · Full text

Medicine, Gynecology, Oncology +13

Randomized phase II trial of carboplatin-paclitaxel (CP) compared to carboplatin-paclitaxel-bevacizumab (CP-B) in advanced (stage III-IV) or recurrent endometrial cancer: The MITO END-2 trial.

Domenica Lorusso, Gabriella Ferrandina, Nicoletta Colombo et al. · Journal of Clinical Oncology · 2015 · 44 citations

Medicine, Oncology, Pharmacology +13

Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response

Elena Massa, Giorgio Astara, Clelia Madeddu et al. · Critical Reviews in Oncology/Hematology · 2008 · 31 citations

Medicine, Oncology, Pharmacology +17

A Nutritional Approach for the Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer

Salvatore Artale, N Grillo, Stefano Lepori et al. · Nutrients · 2022 · 25 citations · Full text

Agriculture, Nutrition, Oncology +17